Skip to main content
Have a personal or library account? Click to login
Expression Analysis of Adrenomedullin and Its Receptors RAMP2/CLR and RAMP3/CLR in Acute Myeloid Leukemia: A Saudi Cohort Study Cover

Expression Analysis of Adrenomedullin and Its Receptors RAMP2/CLR and RAMP3/CLR in Acute Myeloid Leukemia: A Saudi Cohort Study

Open Access
|Apr 2026

References

  1. Huang, P., & Zhang, J. (2025). Global leukemia burden and trends: a comprehensive analysis of temporal and spatial variations from 1990-2021 using GBD (Global Burden of Disease) data. BMC public health, 25(1), 262. https://doi.org/10.1186/s12889-025-21428-w
  2. Huang, J., Chan, S. C., Ngai, C. H., Lok, V., Zhang, L., Lucero-Prisno, D. E., 3rd, Xu, W., Zheng, Z. J., Elcarte, E., Withers, M., & Wong, M. C. S. (2022). Disease Burden, Risk Factors, and Trends of Leukaemia: A Global Analysis. Frontiers in oncology, 12, 904292. https://doi.org/10.3389/fonc.2022.904292
  3. Almasmoum, H. A., Salaka, A. S., Alamri, I. Y., Halabi, W. S., Bokhari, M. M., Hafiz, M. N., & Mujalli, A. (2025). Leukemia Incidence and Demographic Trends in Saudi Arabia, 1997-2022: A Nationwide Registry Analysis. Journal of epidemiology and global health, 15(1), 132. https://doi.org/10.1007/s44197-025-00470-2
  4. WHO, “Saudi Arabia fact sheet - Global Cancer Observatory,” 2022, December 2023, https://gco.iarc.fr/today/data/factsheets/populations/682-saudi-arabia-fact-sheets.pdf.
  5. Schönauer, R., Els-Heindl, S., & Beck-Sickinger, A. G. (2017). Adrenomedullin - new perspectives of a potent peptide hormone. Journal of peptide science : an official publication of the European Peptide Society, 23(7-8), 472–485. https://doi.org/10.1002/psc.2953
  6. Martínez-Herrero S, Martínez A. Adrenomedullin: Not Just Another Gastrointestinal Peptide. Biomolecules. 2022; 12(2):156. https://doi.org/10.3390/biom12020156
  7. Li, H., Yang, W., Wang, S., Zhao, Z., Wang, W., Shi, M., & Li, Y. (2025). Adrenomedullin in Tumorigenesis and Cancer Progression. International journal of molecular sciences, 26(12), 5552. https://doi.org/10.3390/ijms26125552
  8. Liu Y and Zhou C (2025) Integrated pan-cancer analysis of ADM’s role in prognosis, immune modulation and resistance. Front. Immunol. 16:1573250. doi: 10.3389/fimmu.2025.1573250
  9. Wang, H. Y., Wang, F. Z., Chang, R., Wang, Q., Liu, S. Y., Cheng, Z. X., Gao, Q., Zhou, H., & Zhou, Y. B. (2023). Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension. International journal of molecular sciences, 24(4), 3943. https://doi.org/10.3390/ijms24043943
  10. Sacco MA, Gualtieri S, Cordasco F, Tarallo AP, Verrina MC, Princi A, Bruni A, Garofalo E, Aquila I. The Role of Adrenomedullin as a Predictive Marker of the Risk of Death and Adverse Clinical Events: A Review of the Literature. Journal of Clinical Medicine. 2024; 13(16):4847. https://doi.org/10.3390/jcm13164847
  11. Matsuda, Y., Tanaka, M., Zhao, Y., Kakihara, S., Hoshiyama, K., Sakurai, T., Kamiyoshi, A., Ichikawa-Shindo, Y., Kawate, H., Zhang, Y., Guo, Q., Li, P., Li, J., Duan, J., Hayashi, M., Sanjo, H., Murata, T., & Shindo, T. (2025). Adrenomedullin-RAMP2 System Modulates Inflammation and Tissue Repair in Experimental Autoimmune Uveitis Via T-Cell and M2 Macrophage Regulation. Investigative ophthalmology & visual science, 66(6), 12. https://doi.org/10.1167/iovs.66.6.12
  12. Chauhan, M., Yallampalli, U., Banadakappa, M., & Yallampalli, C. (2015). Involvement of Receptor Activity-Modifying Protein 3 (RAMP3) in the Vascular Actions of Adrenomedullin in Rat Mesenteric Artery Smooth Muscle Cells. Biology of reproduction, 93(5), 116. https://doi.org/10.1095/biolreprod.115.134585
  13. Holm, A., Edvinsson, J. C. A., Krause, D. N., & Edvinsson, L. (2025). RAMP1-dependent hormonal regulation of CGRP and its receptor in the trigeminal ganglion. The journal of headache and pain, 26(1), 142. https://doi.org/10.1186/s10194-025-02071-7
  14. Oehler, M., Fischer, D., Orlowska-Volk, M. et al. Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer 89, 1927–1933 (2003). https://doi.org/10.1038/sj.bjc.6601397
  15. Liu, Y., & Zhou, C. (2025). Integrated pan-cancer analysis of ADM’s role in prognosis, immune modulation and resistance. Frontiers in immunology, 16, 1573250. https://doi.org/10.3389/fimmu.2025.1573250
  16. Wang, L., Gala, M., Yamamoto, M., Pino, M. S., Kikuchi, H., Shue, D. S., Shirasawa, S., Austin, T. R., Lynch, M. P., Rueda, B. R., Zukerberg, L. R., & Chung, D. C. (2014). Adrenomedullin is a therapeutic target in colorectal cancer. International journal of cancer, 134(9), 2041–2050. https://doi.org/10.1002/ijc.28542
  17. Benyahia, Z., Gaudy-Marqueste, C., Berenguer-Daizé, C., Chabane, N., Dussault, N., Cayol, M., Vellutini, C., Djemli, A., Nanni, I., Beaufils, N., Mabrouk, K., Grob, J. J., & Ouafik, L. (2022). Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angio-genesis and Lymphangiogenesis. Cancers, 14(23), 5909. https://doi.org/10.3390/cancers14235909
  18. Shen, J., & Zou, Y. (2024). Diagnostic value of contrast-enhanced CT in clear cell renal cell carcinoma: a systematic review and meta-analysis. BMC urology, 24(1), 189. https://doi.org/10.1186/s12894-024-01574-w
  19. Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P. Factors Associated with recovery of renal function following radical nephrectomy for kidney neoplasms. Clin J Am Soc Nephrol. 2016;11(1):101–7.
  20. Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, et al. Long-term renal function recovery following radical nephrectomy for kidney Cancer: results from a Multicenter Confirmatory Study. J Urol. 2018;199(4):921–6.
  21. Simonetti G, Angeli D, Petracci E, Fonzi E, Vedovato S, Sperotto A, Padella A, Ghetti M, Ferrari A, Robustelli V, Di Liddo R, Conconi MT, Papayannidis C, Cerchione C, Rondoni M, Astolfi A, Ottaviani E, Martinelli G and Gottardi M (2021) Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia. Front. Oncol. 11:684396. doi: 10.3389/fonc.2021.684396
  22. AlQahtani, N.A.A., S. Aljabr, E.H.O. Kutbi, M. Alonazi, R.S. Bhat and S. Al-Daihan, 2025. Expression patterns of adrenomedullin and its receptors in
  23. breast cancer among Saudi patients. Int. J. Pharmacol., 21: 200-208.
  24. Benyahia Z, Gaudy-Marqueste C, Berenguer-Daizé C, Chabane N, Dussault N, Cayol M, Vellutini C, Djemli A, Nanni I, Beaufils N, et al. Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis. Cancers. 2022; 14(23):5909. https://doi.org/10.3390/cancers14235909
  25. Larrue, C., Guiraud, N., Mouchel, P. L., Dubois, M., Farge, T., Gotanègre, M., Bosc, C., Saland, E., Nicolau-Travers, M. L., Sabatier, M., Serhan, N., Sahal, A., Boet, E., Mouche, S., Heydt, Q., Aroua, N., Stuani, L., Kaoma, T., Angenendt, L., Mikesch, J. H., … Sarry, J. E. (2021). Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Nature communications, 12(1), 422. https://doi.org/10.1038/s41467-020-20717-9
  26. Maru, G. B., Hudlikar, R. R., Kumar, G., Gandhi, K., & Mahimkar, M. B. (2016). Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials. World journal of biological chemistry, 7(1), 88–99. https://doi.org/10.4331/wjbc.v7.i1.88
  27. Lv, Yp., Peng, Ls., Wang, Qh. et al. Degranulation of mast cells induced by gastric cancer-derived adrenomedullin prompts gastric cancer progression. Cell Death Dis 9, 1034 (2018). https://doi.org/10.1038/s41419-018-1100-1
  28. Zhu, Q., Tian, G., Tang, Z., Gao, J., & Tan, Y. (2016). Adrenomedullin Promotes the Proliferation and Inhibits Apoptosis of Dental Pulp Stem Cells Involved in Divergence Pathways. Journal of endodontics, 42(9), 1347–1354. https://doi.org/10.1016/j.joen.2016.06.001
  29. Simonetti, G., Angeli, D., Petracci, E., Fonzi, E., Vedovato, S., Sperotto, A., Padella, A., Ghetti, M., Ferrari, A., Robustelli, V., Di Liddo, R., Conconi, M. T., Papayannidis, C., Cerchione, C., Rondoni, M., Astolfi, A., Ottaviani, E., Martinelli, G., & Gottardi, M. (2021). Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia. Frontiers in oncology, 11, 684396. https://doi.org/10.3389/fonc.2021.684396
  30. Hendrikse, E. R., Liew, L. P., Bower, R. L., Bonnet, M., Jamaluddin, M. A., Prodan, N., Richards, K. D., Walker, C. S., Pairaudeau, G., Smith, D. M., Rujan, R. M., Sudra, R., Reynolds, C. A., Booe, J. M., Pioszak, A. A., Flanagan, J. U., Hay, M. P., & Hay, D. L. (2020). Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based Receptors. ACS pharmacology & translational science, 3(2), 305–320. https://doi.org/10.1021/acsptsci.9b00108
  31. Chang, C. L., & Hsu, S. Y. (2013). Roles of CLR/RAMP receptor signaling in reproduction and development. Current protein & peptide science, 14(5), 393–406. https://doi.org/10.2174/13892037113149990056
  32. Li H, Yang W, Wang S, Zhao Z, Wang W, Shi M, Li Y. Adrenomedullin in Tumorigenesis and Cancer Progression. International Journal of Molecular Sciences. 2025; 26(12):5552. https://doi.org/10.3390/ijms26125552
  33. Hay, D. L., & Pioszak, A. A. (2016). Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles. Annual review of pharmacology and toxicology, 56, 469–487. https://doi.org/10.1146/annurev-pharmtox-010715-103120
  34. Shindo, T., Tanaka, M., Kamiyoshi, A., Ichikawa-Shindo, Y., Kawate, H., & Sakurai, T. (2022). Receptor Activity Modifying Protein RAMP Sub-Isoforms and Their Functional Differentiation, Which Regulates Functional Diversity of Adrenomedullin. Biology, 11(5), 788. https://doi.org/10.3390/biology11050788
  35. Gluexam, T., Grandits, A. M., Schlerka, A., Nguyen, C. H., Etzler, J., Finkes, T., Fuchs, M., Scheid, C., Heller, G., Hackl, H., Harrer, N., Sill, H., Koller, E., Stoiber, D., Sommergruber, W., & Wieser, R. (2019). CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia. International journal of molecular sciences, 20(23), 5826. https://doi.org/10.3390/ijms20235826
  36. Jacob, A., Wu, R., & Wang, P. (2012). Regulation of RAMP expression in diseases. Advances in experimental medicine and biology, 744, 87–103. https://doi.org/10.1007/978-1-4614-2364-5_8
  37. Liddo RD, Bridi D, Gottardi M et al., “Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells,” International Journal of Oncology, vol. 48, no. 4, pp. 1659–1669, 2016.
  38. Shindo T, Tanaka M, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Sakurai T. Receptor Activity Modifying Protein RAMP Sub-Isoforms and Their Functional Differentiation, Which Regulates Functional Diversity of Adrenomedullin. Biology. 2022; 11(5):788. https://doi.org/10.3390/biology11050788
  39. Wiese W, Galita G, Siwecka N, Rozpędek-Kamińska W, Slupianek A, Majsterek I. Endoplasmic Reticulum Stress in Acute Myeloid Leukemia: Pathogenesis, Prognostic Implications, and Therapeutic Strategies. International Journal of Molecular Sciences. 2025; 26(7):3092. https://doi.org/10.3390/ijms26073092
  40. Liu, A., Yu, C., Peng, X., Liu, J., Zhang, Y., Ma, Y., Wei, K., & Lai, Y. (2025). Upregulation of EMP3 in acute myeloid leukemia: a study based on data mining, RT-qPCR and immunohistochemistry. Discover oncology, 16(1), 1668. https://doi.org/10.1007/s12672-025-03368-
Language: English
Page range: 46 - 54
Published on: Apr 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Sadeem Aljabr, Ramesa Shafi Bhat, Nada Al Qahtani, Emad Kutbi, Mona Alonazi, Shahad AlOtaiby, Sooad Al-Daihan, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.